Journal
BIOCONJUGATE CHEMISTRY
Volume 23, Issue 4, Pages 671-682Publisher
AMER CHEMICAL SOC
DOI: 10.1021/bc200264c
Keywords
-
Categories
Funding
- National Heart, Lung and Blood Institute of the National Institutes of Health [HHSN268201000046C]
Ask authors/readers for more resources
Over the past decade, positron emitter labeled nanoparticles have been widely used in and substantially improved for a range of diagnostic biomedical research. However, given growing interest in personalized medicine and translational research, a major challenge in the field will be to develop disease-specific nanoprobes with facile and robust radiolabeling strategies and that provide imaging stability, enhanced sensitivity for disease early stage detection, optimized in vivo pharmacokinetics for reduced nonspecific organ uptake, and improved targeting for elevated efficacy. This review briefly summarizes the major applications of nanoparticles labeled with positron emitters for cardiovascular imaging, lung diagnosis, and tumor theranostics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available